BGMS (Bio Green Med Solution, Inc. Common Stock) Stock Analysis - AI Report
Bio Green Med Solution, Inc. Common Stock (BGMS) is a publicly traded the market company. As of May 21, 2026, BGMS trades at $0.96 with a market cap of $5.35M and a P/E ratio of -0.15. BGMS moved +1.13% today. Year to date, BGMS is -29.60%; over the trailing twelve months it is flat. Its 52-week range spans $0.73 to $6.70. Rallies surfaces BGMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on BGMS?
Rallies AI research for BGMS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Yap Kim Choy sold 28.54K (~$48.52K) on Nov 5, 2025.
Yap Kim Choy sold 112.26K (~$202.85K) on Oct 30, 2025.
Kua Khai Loon sold 242.48K (~$436.46K) on Oct 30, 2025.
BGMS Analyst Consensus
BGMS analyst coverage data. Average price target: $0.00.
Common questions about BGMS
What is the AI research view on BGMS?
Rallies AI research for BGMS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for BGMS?
Rallies AI research for BGMS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is BGMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BGMS. It does not provide personalized investment advice.
